These disclosures are from a 13D filed with the Securities and Exchange Commission. 13D is filed within 10 days after the company acquires his 5% or more shares in any type of securities of the company. Any subsequent changes in ownership or intent must be reported on the amended return. This document is from February 28, 2024 to March 6, 2024. Source: VerityData
city trend
Investment in Fund 1 raised its stake in the urban apparel and accessories retailer to 1,439,146 shares. Fund 1 purchased 109,804 shares of CitiTrend stock between February 29 and March 1 at prices between $30.51 and $31.33 per share. Fund 1 signed a cooperation agreement with CitiTrend on February 28, pursuant to which CitiTrend will appoint David Heath, Charles Liu and Michael Kvitko to the Board of Directors until he is elected at the 2024 Annual General Meeting. Appoint as an observer.
Following the acquisition, Fund 1 now owns 16.8% of Citi Trends' outstanding shares.
Increase in number of shares held
Arctis Biotherapeutics
Frasier Life Sciences Management increased its stake in the medical dermatology company to 8,785,284 shares. Frazier accomplished this by purchasing 21,052 Arcutis shares on March 4 at a price of $9.50 per share. In connection with this stock purchase, Frazier entered into a lock-up agreement with Archutis, agreeing not to dispose of or hedge any common stock or convertible notes until April 28th without prior written consent. did.
Following the acquisition, Frazier now owns 7.8% of Arcutis' outstanding shares.
Advertisement – SCROLL TO CONTINUE
Decrease in stock holdings
peabody energy
Elliott Investment Management Reduced stake in metallurgical and thermal coal production company to 5,922,757 shares. Elliott accomplished this by selling 3,707,243 Peabody shares between February 23 and March 1 at prices between $24.79 and $25.19 per share.
As a result of the sale, Elliott now owns 4.6% of Peabody's tradable stock, below the 5% threshold that would require reporting any further sales of Peabody stock. Peabody stock is up about 11% since the beginning of the year.
GMS
Coliseum Capital Management reduced its holdings in the building materials company to 1,962,751 shares. Coliseum and two affiliated companies sold his 684,344 shares of GMS stock from February 12 to February 28 at prices ranging from $88 to $91.78 per share. The sale consisted of 551,623 shares sold by Coliseum and an additional 132,721 shares sold by investment advisory clients of Coliseum affiliates.
Advertisement – SCROLL TO CONTINUE
Following this sale, Coliseum now owns 4.9% of GMS's outstanding shares, which is slightly below the threshold that would require Coliseum to report further sales of GMS stock.
par pacific holdings
stock group investment reduced its stake in the energy company to 2,179,801 shares. Equity Group completed the sale by selling 1,168,629 shares of Par Pacific stock between February 29 and March 4 at prices between $36.32 and $37.28 per share.
Following this sale, Equity Group now owns 3.7% of Par Pacific's outstanding shares, which is below the threshold required to report additional Par Pacific stock sales. ing.
Email: editors@barrons.com
